Impact of graft size on postoperative thrombocytopenia in living donor liver transplant

Arch Surg. 2007 Nov;142(11):1054-8. doi: 10.1001/archsurg.142.11.1054.

Abstract

Hypothesis: Perioperative variables, including portal venous pressure (PVP) and graft size, can predict thrombocytopenia after living donor liver transplant (LDLT).

Design: Retrospective analysis.

Setting: University hospital.

Patients: Forty-five adult patients with liver cirrhosis who underwent LDLT without splenectomy (n = 38) or with simultaneous splenectomy (n = 7).

Main outcome measures: Preoperative and postoperative platelet counts and perioperative variables of recipient age, preoperative Model for End-Stage Liver Disease score, donor age, graft volume to standard liver volume ratio, PVP, cold and warm ischemia times, blood loss, and surgical complications.

Results: In the 38 recipients who did not undergo splenectomy, there was a strong correlation between PVP at the completion of the transplant and the platelet count (at 14 and 28 days and at 3 months). A high PVP (> or = 25 mm Hg) correlated with posttransplant thrombocytopenia, as did a small graft. Patients undergoing a simultaneous splenectomy had sufficient platelet levels at each measurement, irrespective of the graft volume.

Conclusions: Portal venous pressure and graft size were associated with posttransplant thrombocytopenia. Splenectomy is an option in cases with a high PVP or a small graft, especially for patients receiving postoperative interferon therapy for hepatitis C virus.

MeSH terms

  • Adult
  • Blood Pressure
  • Female
  • Hepatitis C / drug therapy
  • Hepatitis C / surgery
  • Hospitals, University
  • Humans
  • Interferons / therapeutic use
  • Liver Cirrhosis / surgery
  • Liver Transplantation / adverse effects*
  • Living Donors
  • Male
  • Middle Aged
  • Organ Size
  • Portal Vein / physiopathology*
  • Retrospective Studies
  • Splenectomy
  • Thrombocytopenia / etiology
  • Thrombocytopenia / physiopathology*
  • Transplants*

Substances

  • Interferons